期刊文献+

高血压患者良性前列腺增生症状影响因素分析 被引量:2

Influencing factors of IPSS and Qmax in middle aged and old male patients with essential hypertension
原文传递
导出
摘要 目的探讨中老年男性高血压人群中,国际前列腺增生症状评分(IPSS)和最大尿流率(Qmax)的影响因素。方法对安徽安庆农村地区50~75岁男性原发性高血压患者435例进行流行病调查,采用多元Logistic回归分析IPSS和最大尿流率的影响因素。结果多元Logistic回归分析结果显示:影响中老年男性高血压患者IPSS评分的主要因素有年龄(OR2.25,95%CI=1.45~3.48)和残余尿量(OR2.98,95%CI=1.92~4.63),影响最大尿流率的主要因素有年龄(OR2.22,95%CI=1.43~3.45),前列腺体积(OR2.39,95%CI=1.42~4.04),残余尿量(OR2.09,95%CI=1.34~3.25)和吸烟(OR0.56,95%CI=0.31~0.99)。结论在中老年男性高血压患者人群中,年龄和残余尿量是良性前列腺增生主观症状的主要影响因素;年龄、前列腺体积以及残余尿量是最大尿流率的主要影响因素;吸烟可能是最大尿流率减小的保护因素。 Objective To explore the influencing factors of international prostate syndrome score (IPSS) and maximum flow rate (Qmax) in middle aged and old male patients with essential hypertension in rural commuruty. Methods A population - based epidemiological investigation was conducted to collect 435 hypertensive male patients of 50 to 75 years old in Anqing,Anhui. Logistic regression was used for analysis of influencing factors. Results Logistic regression analysis showed that the main influencing factors of IPSS were age( OR 2. 25,95% CI = 1.45 - 3.48) and post void residual( OR 2.98,95% CI = 1.92 -4.63) ;the main influencing factors of Qmax were age ( OR 2.22,95% CI = 1.43 - 3.45) ,prostate volume ( OR 2.39,95 % CI = 1.42 -4. 04 ), post void residual ( OR 2. 09,95 % CI = 1.34 - 3.25 ) and smoking ( OR 0. 56, 95 % CI = 0. 31 - 0. 99 ). Conclusion Age and post void residual are main influencing factors of IPSS. Main influencing factors of Qmax are age,prostate volume, post void residual. Cigarette using may reduce the risk for the decreased level of Qmax.
出处 《中国公共卫生》 CAS CSCD 北大核心 2009年第4期456-458,共3页 Chinese Journal of Public Health
关键词 高血压 国际前列腺增生症状评分 良性前列腺增生 中老年男性 hypertension IPSS benign prostatic hyperplasia middle and old age male
  • 相关文献

参考文献10

二级参考文献40

  • 1顾方六,山岗志,王通生,薛兆英.北京城乡良性前列腺增生发病的差异[J].中华泌尿外科杂志,1995,16(7):387-390. 被引量:61
  • 2Maruenda J, Bhatnagar V, Lowenthal DT. HyPertension in the elderly with coexisting benign prostatic hyperplasia. Urology, 1999, 53(Suppl 3A):7-12. 被引量:1
  • 3Hammarsten J, Hogstedt B, Holthuis N, et al. Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis, 1998, 1:157-162. 被引量:1
  • 4Hammarsten J, Hogstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol,2001, 39:151-158. 被引量:1
  • 5Nicolas Torralba JA, Tornero Ruiz J, Banon Perez V, et al. Relation between hypertension and clinical cases of benign prostatic hyperplasia. Arch Esp Urol,2003,56:355-358. 被引量:1
  • 6Golomb E, Rosenzweig N, Eilam R, et al. Spontaneous hyperplasia of the ventral lobe of the prostate in aging genetically hypertensive rats. J Androl, 2000,21:58-64. 被引量:1
  • 7山岗志,邓方明,王行环,顾方六.中老年人前列腺体积增长的城乡差异[J].中华泌尿外科杂志,1997,18(3):134-136. 被引量:30
  • 8Platz FA,Rimm EB,Kawachi I,et al.Alcohol consumption,cigarette smoking,and risk of benign prostatic hyperplasia[J].Am J Epidemiol,1999,149:106-105. 被引量:1
  • 9Rohrmann S,Crespo CJ,Weber JR,et al.Association of smoking,alcohol and physical activity with LUTS in older American men[J].BJU Int,2005,96:77-82. 被引量:1
  • 10Gass R.Benign prostatic hyperplasia:the opposite effects of alcohol and coffee intake[J].BJU Int,2002,90:649-654. 被引量:1

共引文献266

同被引文献18

  • 1郭利君,张祥华,李培军,那彦群.良性前列腺增生与原发性高血压的相关性研究[J].中华外科杂志,2005,43(2):108-111. 被引量:59
  • 2李培军,张祥华,郭利君,那彦群.高脂血症与良性前列腺增生相关性的临床研究[J].中华外科杂志,2005,43(6):387-389. 被引量:33
  • 3石泉,姜宁,王国增,赵玉隆,章璟,李健,顾燕,许梦清,马杰.浦东新区50岁以上男性前列腺增生症流行病学调查[J].中国男科学杂志,2006,20(7):36-38. 被引量:36
  • 4Meigs JB,Mohr B,Barry MJ,et al.Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men[J].J Clin Epidemiol,2001,54(9):935-944. 被引量:1
  • 5Ozden C,Ozdal OL,Urgancioglu G,et al.The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia[J].Eur Urol,2007,51(1):199-203. 被引量:1
  • 6Cholewa BC,Meister CJ,Mattson DL.Importance of the rennin-angiotensin system in the regulation of arterial blood pressure in conscious mice and rats[J].Acta Physiol Scand,2005,l83(3):309-320. 被引量:1
  • 7Lepor H.Alpha blockers for the treatment of benign prostatic hyperplasia[J].Rev Urol,2007,9(4):181-190. 被引量:1
  • 8O′Leafy MP.Treatment and pharmacologic management of BPH in the context of common comorbidities[J].Am J Manag Care,2006,12(1):129-140. 被引量:1
  • 9Hammarsten J,Hogstedt B.Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia[J].Eur Urol,2001,39(2):151-158. 被引量:1
  • 10Golomb E,Rosenzweig N,Eilam R,et al.Spontaneous hyperplasia of the ventral lobe of the prostate in aging genetically hypertensive rat[J].J Androl,200,21(1):58-64. 被引量:1

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部